Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-29T20:23:15.320Z Has data issue: false hasContentIssue false
  • English
  • Français

Cerebral Fat Embolism as the Cause of Death in a Case of Schizophrenia Treated with Triazol (Azoman)

Published online by Cambridge University Press:  08 February 2018

G. S. Nightingale  and
A. Meyer
G. S. Nightingale
Affiliation:
Brentwood Mental Hospital, Essex, and
A. Meyer
Affiliation:
Central Pathological Laboratory, Mental Hospital Department, L.C.C
Get access Rights & Permissions [Opens in a new window]

Extract

There has been an extensive literature on accidents occurring during cardiazol treatment, and since the largely conflicting pathogenic view-points have been discussed in recent reviews (Gross and Gross-May, 1939; Kennedy, 1940; Wyllie, 1940), there is no need for their detailed enumeration. Gross and Gross-May, whose paper was unfortunately not available to us in the original, recently summed up the more important causes of accidents, grouping them into mechanical disorders, particularly of the osseous, tendinous and muscular system; disturbances of the vascular system—arrhythmia, auricular fibrillation, syncope and vascular spasm due to the specific action of cardiazol; and finally, respiratory disturbances—arrest of respiration, pulmonary embolism, and abscess due to thrombophlebitis at the site of injection.

Type
Part I.—Original Articles
Information
Journal of Mental Science , Volume 86 , Issue 364 , September 1940 , pp. 819 - 826
Copyright
Copyright © Royal College of Psychiatrists, 1940 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Atkin, I. (1939), Lancet, 236, 435.CrossRefGoogle Scholar
Bodechtel, G., and Mueller, G. (1930), Zcitschr. f. d. ges. Neurol., 124, 764.CrossRefGoogle Scholar
Braunmuhl, A. vox (1938), Psychiat.-Neurol. Wochenschr., 45, 515.Google Scholar
Cammermeyer, J. (1937), Acta Psychiat., 12, 333.CrossRefGoogle Scholar
Gross, M., and Gross-May, G. (1939), Journ. Beige de Neurol., 39, 336.Google Scholar
Harris, A. (1939), Lancet, 237, 958.Google Scholar
Hobson, J. A. (1938), in Board of Control Report on Cardiazol Treatment. H.M.S.O., London.Google Scholar
Jansen, J., and Waaler, E. (1940), Arch. f. Psychiat., 111, 62.CrossRefGoogle Scholar
Kennedy, A. (1940), Journ. Neurol. and Psychiat., 3, 49.CrossRefGoogle Scholar
Neubuerger, K. (1925), Zeitschr. f. d. ges. Neurol., 95, 278.Google Scholar
Strauss, H. (1933), Zentralbl. f. d. ges. Neurol., 66, 385.Google Scholar
Thorpe, F. T. (1939), Lancet, 237, 1139.Google Scholar
Walk, A., and Mayer-Gross, W. (September, 1938), Journ. Ment. Sci., 84, 637.Google Scholar
Weimann, W. (1929), Zeitschr. f. d. ges. Neurol., 120, 68.Google Scholar
Wilson, S. A. K. (1940), Neurology. Edward Arnold, London.Google Scholar
Wyllie, A. M. (March, 1940), Journ. Ment. Sci., 86, 248.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.